Aurore Morello

1.9k total citations · 2 hit papers
16 papers, 1.4k citations indexed

About

Aurore Morello is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Aurore Morello has authored 16 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 5 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in Aurore Morello's work include CAR-T cell therapy research (11 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Immunotherapy and Immune Responses (3 papers). Aurore Morello is often cited by papers focused on CAR-T cell therapy research (11 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Immunotherapy and Immune Responses (3 papers). Aurore Morello collaborates with scholars based in United States and France. Aurore Morello's co-authors include Prasad S. Adusumilli, Michel Sadelain, Jonathan Villena‐Vargas, David R. Jones, Leonid Cherkassky, Yang Feng, Dimiter S. Dimitrov, Zachary E. Tano, Vladimir Ponomarev and Maxim A. Moroz and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Aurore Morello

14 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition

2016 803 citations Leonid Cherkassky, Aurore Morello et al. Journal of Clinical Investigation profile →
Mesothelin-Targeted CARs: Driving T Cells to Solid Tumors

2015 367 citations Aurore Morello, Michel Sadelain et al. Cancer Discovery profile →

Peers

Aurore Morello

ONCOL

IMMUN

GENET

Connie P.M. Duong United States

Xiaojun Qian China

Lynsey M. Whilding United Kingdom

Yukimi Sakoda Japan

Monica Casucci Italy

David M. Davies United Kingdom

Qiangzhong Ma United States

Navin K. Chintala United States

Ana C. Parente‐Pereira United Kingdom

Mary A. Black United States

Connie P.M. Duong United States

Aurore Morello

1.1k ×0.9

ONCOL

683 ×1.3

IMMUN

259 ×0.7

379 ×1.1

313 ×1.0

GENET

Citations per year, relative to Aurore Morello Aurore Morello (= 1×) peers Connie P.M. Duong

Countries citing papers authored by Aurore Morello

Since Specialization

Citations

This map shows the geographic impact of Aurore Morello's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aurore Morello with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aurore Morello more than expected).

Fields of papers citing papers by Aurore Morello

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aurore Morello. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aurore Morello. The network helps show where Aurore Morello may publish in the future.

Co-authorship network of co-authors of Aurore Morello

This figure shows the co-authorship network connecting the top 25 collaborators of Aurore Morello. A scholar is included among the top collaborators of Aurore Morello based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aurore Morello. Aurore Morello is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Morello, Aurore, Justine Durand, Isabelle Girault, et al.. (2023). 1370 Anti-PD-1/IL-7v immunocytokine favors proliferation & survival of TCF1+ stem like memory T cells and a durable in vivo efficacy in monotherapy or using combinatorial strategy. SHILAP Revista de lepidopterología. A1526–A1526. 2 indexed citations

Morello, Aurore, Justine Durand, Isabelle Girault, et al.. (2022). 1366 Anti-PD-1/IL-7v bispecific antibody promotes TCF1+ stem like T cells expansion and long-lasting in vivo efficacy. Regular and Young Investigator Award Abstracts. 1 indexed citations

Poirier, Nicolas, et al.. (2022). 826 IL7R TME expression correlates with immunotherapy response and is associated with T-cell stemness with decreased apoptosis. Regular and Young Investigator Award Abstracts. A861–A861. 2 indexed citations

Hocine, Hocine R., Maxim A. Moroz, Srijita Banerjee, et al.. (2021). Imaging CAR T-cell kinetics in solid tumors: Translational implications. Molecular Therapy — Oncolytics. 22. 355–367. 30 indexed citations

Morello, Aurore, Justine Durand, Virginie Thépenier, et al.. (2020). Abstract 910: A novel bifunctional anti-PD-1 IL-7 fusion protein to reinvigorate exhausted T cell and disarms Treg suppressive activity. Cancer Research. 80(16_Supplement). 910–910. 2 indexed citations

Eguchi, Takashi, et al.. (2019). OA14.03 Clinical Rationale and Preclinical Evidence for Chimeric Antigen Receptor (CAR) T Cell Therapy Clinical Trial in KRAS-Mutant Lung Cancer. Journal of Thoracic Oncology. 14(10). S244–S244. 2 indexed citations

Gauttier, Vanessa, Sabrina Pengam, Justine Durand, et al.. (2018). Abstract 1684: Selective SIRPa blockade potentiates dendritic cell antigen cross-presentation and triggers memory T-cell antitumor responses. Cancer Research. 78(13_Supplement). 1684–1684. 1 indexed citations

Durand, Justine, Vanessa Gauttier, Aurore Morello, et al.. (2018). Abstract 1753: SIRPa inhibition monotherapy leads to dramatic change in solid tumor microenvironment and prevents metastasis development. Cancer Research. 78(13_Supplement). 1753–1753. 4 indexed citations

Morello, Aurore, et al.. (2017). MA04.11 Mechanistic Insights into CAR T-Cell Efficacy in the Treatment of Heterogenous Antigen Expressing Lung Adenocarcinoma. Journal of Thoracic Oncology. 12(1). S363–S364. 2 indexed citations

10.

Morello, Aurore, Nan Chen, Leonid Cherkassky, et al.. (2017). OA02.06 Converting Tumor-Mediated PD-L1 Inhibition into CAR T-Cell Costimulation to Potentiate Thoracic Cancers Immunotherapy. Journal of Thoracic Oncology. 12(1). S249–S249.

11.

Morello, Aurore, et al.. (2016). CAR T-cell intrinsic PD-1 checkpoint blockade: A two-in-one approach for solid tumor immunotherapy. OncoImmunology. 6(2). e1273302–e1273302. 117 indexed citations

12.

Cherkassky, Leonid, Aurore Morello, Jonathan Villena‐Vargas, et al.. (2016). Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition. Journal of Clinical Investigation. 126(8). 3130–3144. 803 indexed citations breakdown →

13.

Morello, Aurore, Michel Sadelain, & Prasad S. Adusumilli. (2015). Mesothelin-Targeted CARs: Driving T Cells to Solid Tumors. Cancer Discovery. 6(2). 133–146. 367 indexed citations breakdown →

14.

Cherkassky, Leonid, Jonathan Villena‐Vargas, Aurore Morello, et al.. (2014). Mesothelin-targeted T Cells Gene-Engineered with 4-1BB Costimulation Overcome Tumor-Mediated Immunoinhibition and Eradicate Established Solid Tumors. Journal of the American College of Surgeons. 219(3). S134–S134. 1 indexed citations

15.

Daburon, Sophie, Christel Devaud, Pierre Costet, et al.. (2013). Functional Characterization of a Chimeric Soluble Fas Ligand Polymer with In Vivo Anti-Tumor Activity. PLoS ONE. 8(1). e54000–e54000. 15 indexed citations

16.

Morello, Aurore, Sophie Daburon, Michel Castroviejo, et al.. (2013). Enhancing Production and Cytotoxic Activity of Polymeric Soluble FasL-Based Chimeric Proteins by Concomitant Expression of Soluble FasL. PLoS ONE. 8(8). e73375–e73375. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact